Willem J. Remme

Research interests

Publications

• Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)

  Heart · 2007 · 10.1136/hrt.2006.092379

• The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET

  European Heart Journal · 2006 · 10.1093/eurheartj/ehl012

• Antiarrhythmic effect of carvedilol after acute myocardial infarction

  Journal of the American College of Cardiology · 2005 · 10.1016/j.jacc.2004.09.076

• Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

  European Heart Journal · 2005 · https://doi.org/10.1093/eurheartj/ehi204

• Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial

  European Heart Journal · 2005 · 10.1093/eurheartj/ehi386

• Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

  The Lancet · 2003 · https://doi.org/10.1016/s0140-6736(03)13800-7

• Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

  New England Journal of Medicine · 2003 · https://doi.org/10.1056/nejmoa030207

• Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

  ACC Current Journal Review · 2003 · 10.1016/s1062-1458(03)00290-3

• Comprehensive Guidelines for the Diagnosis and Treatment of Chronic Heart Failure Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology

  European Journal of Heart Failure · 2002 · 10.1016/s1388-9842(01)00231-8

• The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data

  The American Journal of Cardiology · 2001 · 10.1016/s0002-9149(01)01878-1

• The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction

  Cardiovascular Drugs and Therapy · 2001 · 10.1023/a:1011119003788

• Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure

  Journal of the American College of Cardiology · 2000 · 10.1016/s0735-1097(00)00961-x

• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

  New England Journal of Medicine · 1999 · https://doi.org/10.1056/nejm199909023411001

• The treatment of heart failure

  European Heart Journal · 1997

• Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial.

  Heart · 1996 · 10.1136/hrt.76.3.223

• Reproducibility and relation to mean heart rate of heart rate variability in normal subjects and in patients with congestive heart failure secondary to coronary artery disease

  The American Journal of Cardiology · 1991 · 10.1016/0002-9149(91)90327-h

• Early thrombolysis in acute myocardial infarction: Limitation of infarct size and improved survival

  Journal of the American College of Cardiology · 1986 · 10.1016/s0735-1097(86)80329-1

• IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION

  The Lancet · 1985 · 10.1016/s0140-6736(85)90584-7

Current projects

No projects listed.